Axon guidance molecules (AGMs) are involved in several developmental processes in which determining directionality is important, such as body axis formation, neuronal migration, and axonal growth [1]. However, recent studies have revealed that AGMs are also involved in immune and inflammatory responses in peripheral organs/tissues and the central nervous system (CNS), postnatally [2-4]. In particular, there is evidence that different combinations of AGM ligand-receptor interactions are involved in neuroinflammation [5-7], which results from a series of immunological and inflammatory processes occurring within the nervous system. Various pro-inflammatory stimuli activate those processes, including pathogenic insults such as viral or bacterial infections, autoimmune responses, traumatic injuries, and proteinopathies. Neuroinflammation is thought to be of critical importance to degenerative brain diseases such as Alzheimer' s disease, Parkinson' s disease, amyotrophic lateral sclerosis, and multiple sclerosis [8-10]. Recently, multiple studies tried to elucidate the precise mechanisms underlying neuroinflammation and the resulting neurodegenerative diseases and to identify relevant therapeutic solutions. However, how neuroinflammation and associated neurodegenerative disorders are triggered and regulated remains poorly understood. Axon guidance is the neurodevelopmental process whereby axons find the correct direction of growth across the developing nervous system to reach appropriate targets for their neurons [11]. The main functions of neurons are receiving, producing, relaying, integrating, and saving information. Axon guidance contributes to the construction and setting up of the 'infrastructure' that allows